Trial Profile
Randomized Phase II Screening Trial of Docetaxel Plus Prednisolone With or Without Androgen Deprivation Treatment in Castrate-Resistant Prostatic Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary) ; Docetaxel; Prednisolone
- Indications Prostate cancer
- Focus Therapeutic Use
- 12 Dec 2011 New trial record